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The cytosolic peptidyl-prolyl cisltruns tsomerase cyclophilin from pig kidney can accelerate catalytically the ctsltruns isomerization of prolyl peptide 
bonds. One- and two-dimensional ‘H NMR spectroscopy was used to prove that the polypeptide hormone calcitonin is a substrate for cyclophilin. 
Isomerizatton of only one of the two prolyl peptide bonds is catalyzed significantly. The efficiency of catalysis was calculated by lineshape analysis 
and NOESY spectroscopy. Cyclosporin A completely blocks the effect of the enzyme on the conformational dynamtcs of the polypeptide. 
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1. INTRODUCTION 
Peptidyl-prolyl cisltrans isomerases (PPIases) cat- 
alyse the cisltrans isomerization of prolyl peptide bonds 
in short peptides [l] and accelerate proline limited fold- 
ing steps of proteins [24]. Furthermore, it has been 
discovered that cyclophilin and FK506BP, the specific 
binding proteins for the immunosuppressive drugs cy- 
closporin A (CsA) and FK506, are PPIases [5-81. Bind- 
ing of the drugs results in a strong inhibition of the 
isomerase activity. Recent investigations point to links 
between the immunosuppressive drugs. their binding 
proteins and calcium metabolism. It has been shown 
that the complexes cyclophilin-CsA and FK506BP- 
FK506 bind to and inhibit allosterically the Ca’+-de- 
pendent phosphatase calcineurin [9-l 11. However the 
question of the biological function of the uncomplexed 
PPIases still remains to be answered since the microbial 
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substances FK506 and CsA are not consituents of mam- 
malian cells. Therefore we search for natural substrates 
of these enzymes. Human calcitonin is a 32-residue pep- 
tide hormone of which the sequence is shown in the 
previous column. 
It inhibits osteoclast activity and promotes Ca2’-up- 
take of bones [12]. It is widely used as an anti-osteopo- 
rosis drug, but its mechanism of action still awaits a 
satisfactory explanation. As this polypeptide hormone 
plays a central role in Ca”-metabolism and contains 
two proline residues in its sequence we tested the effect 
of cyclophilin on the cisltrans isomerization of the prolyl 
peptide bonds in human calcitonin by ‘H NMR spec- 
troscopy. Our experiments prove that calcitonin in its 
extended conformation is a substrate for cyclophilin 
showing a catalytic discrimination between the two pro- 
lyl peptide bonds. 
2. MATERIALS AND METHODS 
Human calcttonin was a gift from E. Wtinsch (MPI. Martinsried). 
It was dissolved in 10 mM potassium phosphate at pH 6.0 to a concen- 
tration of 0.86 mM. 10% D,O was used for the lock. 
The purtfication ofcyclophilin IS described m [5] and it was prepared 
for the NMR experiments according to the procedure given in [13] 
Aliquots of a stock solution of 190 ,uM were added to the calcitonin 
sample to a final concentration of 25 PM. The PPlase-activity was 
tested with the isomer-specific chymotrypsin test [5] with CU-Suc- 
AFPF-Cnitroanilide as a substrate before and after the NMR exper- 
iments. 
CsA from Sandoz. Switzerland. was added as powder in excess to 
the calcttonm/cyclophilm-sample and incubated for 8 hours. Remain- 
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mg undissolved CsA was removed by centrifugation. 100% inhibition 
of the isomerase activity was assayed as described above [S]. 
All ‘H NMR measurements were carried out on a GE Omega 500 
MHz NMR spectrometer and transformed using the Omega software. 
Some data manipulation was done with the inhouse software 
MAGNE, written by P. Drakenberg. The NOESY data were acquired 
in the hypercomplex mode with the following parameters: spectral 
width 6410 Hz in both dimensions, 64 transients, 256 time increments 
with 2048 complex points and a mixing time of 300 ms. Shifted sine 
bell squared weight functions were applied in both dimensions and the 
data were zero filled to a final size of 2k x 1 k. Determination of the 
cisltrans interconversion rate by 1D NMR spectroscopy was done by 
lineshape analysis using a program based on the Bloch equations 
modified to take exchange mto account [14]. Calculation of this rate 
by 2D chemical exchange spectroscopy was done as described by 
Bame [15]. 
3. RESULTS 
The sequence specific assignments of the ‘H NMR 
spectrum of human calcitonin have been determined by 
two-dimensional ‘H, 15N and 13C nuclear magnetic reso- 
nance spectroscopy (2D NMR). Nuclear Overhauser 
enhancement spectroscopy (NOESY) connectivities and 
circular dichroism measurements (data not shown) indi- 
cate an extended conformation of calcitonin in water 
with high flexibility (manuscript in preparation). Due to 
the two prolyl residues Pro23 and Pro32 in human calci- 
tonin a maximum of four isomers is expected. Analysis 
of the ‘H NMR spectra reveals the existence of at least 
three different isomers of the hormone with a ratio of 
67 : 25 : 8. Based on the typical NOE-connectivities for 
cis- and [runs- Xaa-Pro peptide bonds [16b], the major 
isomer was found to be the all-truns conformer (67%), 
whereas in the two minor isomers the peptide bonds 
PheZ2-ProZ3 (25%) or Ala3’-Pro32 (8%) are in the cis 
conformation. The amount of the isomer with both pro- 
lyl peptide bonds in the cis conformation is too low to 
be detectable. 
Well resolved signals for the isomers (Fig. 1A) indi- 
cate that the rate of their interconversion is slow on the 
NMR time-scale at room temperature (k < 0.2 ss’). In 
the selected region of the ‘H NMR spectrum only the 
J-protons of the two prolyl residues are located with 
well separated signals for the isomers and therefore use- 
ful to prove an acceleration of their interconversion. 
The NOESY spectrum was used for the assignments 
of the J-protons of Pro23 and Pro32 (Fig. 1 B). The cross 
peaks connect those protons which are in close proxim- 
ity [16a]. The fact that we observe both negative and 
positive cross peaks in a NOESY spectrum proves the 
existence of flexible and more rigid regions in this pol- 
ypeptide. The negative signal at 3.7813.64 ppm and its 
mirror image are assigned to the NOESY cross peaks 
between the two &protons from the more flexible C- 
terminal Pro32-tvans. The positive signal at 3.78/3.58 
ppm is accordingly assigned to the NOESY cross peak 
between the two &protons of ProZ3-trans. The signal at 
3.4813.35 ppm belongs to the two &protons of Pro23-cis. 
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Fig. 1. Expansions of one- and two-dimensional ‘H NMR spectra of 
human calcitonin displaying the d-proton region for Pro*’ and Proj’. 
Panel A shows a 1D spectrum with assignments. The all-trans isomer 
1s labeled with I, the Pro*‘-& Pro”-trans with II and the Pro*‘-trans 
Pro”-as with III, the subscripts t and c indicate the conformation of 
the specific bond. Panel B depicts the corresponding expansion of a 
2D NOESY spectrum with negative peaks shaded. 
No cross peak between the &protons of Pro32-cis was 
detectable, most likely due to unfavorable correlation 
times. The cross peak was, however, observed in a 
TOCSY spectrum allowing the assignment (data not 
shown). 
In addition NOESY spectroscopy can be used to de- 
tect isomerization within a molecule, such as catalyzed 
cisltrans isomerization of a prolyl peptide bond. In that 
case cross peaks between signals from the cis and tram 
isomers are observed [14,17]. 
In order to prove a catalysis of the cisltrans isomeri- 
zation of prolyl peptide bonds in native calcitonin by 
cyclophilin, we recorded ‘H NOESY spectra in the ab- 
sence (Fig. 2A), in the presence of catalytical amounts 
of cyclophilin (Fig. 2B) and after inhibition of cyclo- 
philin by CsA (Fig. 2C). Fig. 2B shows four additional 
cross peaks as a result of magnetisation transfer be- 
tween the S-protons of the cis and trans isomers of Pro23 
199 
Volume 323. number 3 FEBSLETTERS June 1993 
3.6 
3.6 
3.6 
II III1 IIII II1I(lIII Ill1 
3.8 3.7 3.6 3.5 3.4 3.3 
Fig. 2. NOESY spectra showing the catalytic effect of cyclophilin on 
calcitonin and the Inhibition by CsA. The expansion is the same as in 
Fig. 1 B showing positive cross peaks only. Sample and condltlons as 
described in Fig. 1. (A) without cyclophlhn, (B) m the presence of 25 
,uM cyclophilin. (C) sample (B) but incubated with excess of CsA for 
8 h. The effects of cyclophllin are marked: boxes ldentlfy exchange 
cross peaks and circles mark conformational exchange-mediated 
NOESY cross peaks [23] between the J-protons of the Pro’3-cis and 
the Pro’3-tru~zs isomers. 
in the presence of 25 PM cyclophilin. This proves that 
the interconversion between the cis and tram isomers of 
the Phe”-Pro23 peptide bond is accelerated. Such ex- 
change cross peaks are observed for several signals as 
a consequence of differences in chemical shift between 
the two isomers. Omitting those signals, the remaining 
spectrum is that of free calcitonin. This indicates that 
cyclophilin specifically catalyses the cisltrans isomeriza- 
tion of the Proz3 peptide bond of calcitonin. Additional 
support for the enzymatic catalysis results from experi- 
ments with the tight binding cyclophilin inhibitor cy- 
closporin A (CsA), which completely inhibits the isom- 
erase activity of cyclophilin (Fig. 2C). 
Determination of the efficiency of cyclophilin to cata- 
lyze the cisltrans isomerization of calcitonin requires 
knowledge of both the uncatalyzed rate without cyclo- 
philin and the catalyzed rate in the presence of cyclo- 
philin. The uncatalyzed cis -+ trans isomerization rate 
(k,) of the Pro” peptide bond in free human calcitonin 
was measured by ID NMR spectroscopy using line 
shape analysis [14]. The protons bound to Cz in His20 
in the cis and tram isomers show well resolved singlets 
(Fig. 3A) and were therefore used to determine li, and 
the free energy of activation (AG #) for the cisltrans 
isomerization. Fig. 3A-C shows the temperature de- 
pendence of the lineshapes and the corresponding calcu- 
lated spectra with the used cis -+ trans isomerization 
rates. According to the Eyring Equation (l), a plot of 
ln(li =--) ,lT) versus l/T for six temperatures between 
338K and 363K can be linearly fitted with 
r = 23.4 - 9702 x and a correlation coefficient of 
b.9966. Extrapolation of the linear fit to 300K gives a 
k, = 0.03 s-‘. The AG # at this temperature was calcu- 
lated to 83 kJ/mol. 
ln(li, --) ,/7’) = AS #lR + ln(RIN x h) - AH #lR x l/T (1) 
The same His20 signals were used to obtain the rate 
constant in presence of 25 PM cyclophilin (kobs). The 
signal of the cis isomer in the spectrum shows a line 
broadening in the presence of cyclophilin (Fig. 3D) 
compared to the cis signal in the absence of this enzyme 
(Fig. 3A). This effect is due to the accelerated rate of 
interconversion which was calculated as koba = 1.6 s-i by 
line shape analysis [14]. This kobs was compared to the 
value obtained by 2D NMR exchange spectroscopy for 
the same sample. From the ratio of the diagonal peak 
to the exchange cross peak [15] a kobs = 1.3 s-’ was 
obtained showing a good agreement with the results of 
the line shape analysis. 
Interestingly, no catalysis of the Pro3’ peptide bond 
was detectable under these conditions, even though the 
uncatalyzed interconversion rate was the same 
(k, = 0.03 ssi) as that of ProZ3. The value for Pro3’ could 
be determined with the same method as employed for 
Pro”’ but using the cis and trans signals of the /?-protons 
of Ala3i. In the presence of 25 PM cyclophilin, no line 
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Fig. 3. Left column: Expansion of the 1D ‘H NMR spectrum of human calcitonin showing the CIS and rrnn~ signals of the C2-protons of His20 
at the indicated temperatures (A-C) and in the presence (D) and absence (A) of cyclophilin at the same temperature. Right column: Correspondmg 
calculated spectra using line shape analysis [14]; the used cis + trans isomeratron rates k, +, are shown respectively. 
broadening in the 1D spectrum and no exchange 
crosspeaks in the 2D spectrum were observed for signals 
characterizing the cis and tram isomer of the Ala3’- 
Pro3’ peptide bond. Therefore the isomerisation rate is 
smaller than 0.1 s-‘, which is the lower limit detectable 
with these methods. Thus our results clearly show a 
sequence specificity of cyclophilin for Pro23. This is 
somewhat surprising in view of the observation by Hsu 
et al. [18] that cyclophilin will catalyze the cisltrans 
isomerization of small peptides in which Pro is the C- 
terminal amino acid. However the substrate investi- 
gated by Hsu was the free acid whereas calcitonin is 
amidated at its C-terminal proline. 
4. DISCUSSION 
Our results demonstrate for the first time that cyclo- 
philin catalyzes cisltrans interconversion of a fairly 
large polypeptide. Up to now only short peptides or 
refolding proteins have been shown to be substrates for 
cyclophilin [2-5,18,19]. Previous efforts to catalyze cisl 
tram isomerization in the protein calbindin in its native 
state [20] by cyclophilin were not successful. We note, 
however, that even though the prolyl residue is in a 
flexible loop, the protein has a globular and compact 
structure that may result in a steric hindrance of interac- 
tion between the protein and cyclophilin. 
The fact that only the cisltrans isomerization of the 
peptide bond Phe22-Pro’3 and not Ala3’-Pro32 is acceler- 
ated significantly by cyclophilin clearly shows a se- 
quence specifity within one substrate. 
Recent discoveries support evidence for a connection 
between cyclophilin and the important intracellular reg- 
ulatory systems that involve calcium-ions and protein 
phosphorylation [9, lo]. Our experiments prove that cal- 
citonin, a hormone important for the regulation of 
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Ca2+-uptake and Ca2’-homeostasis, is a naturally occur- 
ring substrate for cyclophilin. In the presence of CsA, 
cyclophilin can not catalyse the cisltrans isomerization 
of calcitonin. At times of calcium stress calcitonin pro- 
tects the skeleton by inhibiting osteoclast activity [12]. 
CsA, however, shows the inverse effect producing high 
bone remodeling with resorption exceeding formation 
causing a significant bone loss [2 1,221. Further studies 
will show the biological relevance of our findings. 
Acknowledgements: We thank E. Wtinsch for human calcitonin and 
Bryan Fmn for critical reading of the manuscript. 
REFERENCES 
[I] Fischer, G., Bang, H. and Mech, C. (1984) Biomed. Biochim. 
Acta 43. 1101-1111. 
[2] Lang. K., Schmid. F.X. and Fischer, G. (1987) Nature 329,268 
270. 
[3] Bachinger, H.P.J. (1987) Biol. Chem. 262, 1714417148. 
[4] Lang, K. and Schmid, F.X. (1988) Nature 331, 453455. 
[5] Fischer, G., Wittman-Liebold. B., Lang. K., Kiethaber, T. and 
Schmid. F.X. (1989) Nature 337, 476478. 
[6] Takahashi. N., Hayano, T. and Suzuki, M. (1989) Nature 337, 
473475. 
[7] Hohman, R.J. and Huhsch, T. (1990) New Biol. 2, 6633672. 
[S] Harding, W.M.. Galat. A.. Uehhng, D.E. and Schreiber, S.L. 
(1989) Nature 341, 758-760. 
191 
1101 
1111 
1121 
P31 
[I41 
[I51 
[I61 
u71 
[181 
u91 
m 
Pll 
r=l 
~231 
Friedman, J. and Weissman. I. (1991) Cell 66, 799-806. 
Liu, J., Jesse, D., Farmer, J., Lane, W.S., Friedman. J., Wetss- 
man, I. and Schreiber, S. (1991) Gel 66, 8077815. 
Lin, C.S.. Boltz. R.C., Siekierka, J.J. and Sigal. N.H. (1991) Cell 
Immunol. 133,269%284. 
Azria, M (1989) The Calcitonins Physiology and Pharmacology 
Karger, Basel, Switzerland. 
Hiibner, D.. Drakenberg. T., Forsen, S. and Fischer. G. (1991) 
FEBS Lett. 284, 79-81. 
Sandstrom, J. (1982) Dynamic NMR SPectroscopy. Academic 
Press. London. 
Baine. P. (1986) Magn Reson. Chem. 24, 304307. 
Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids. Wiley, 
New York. a. p.112. b. pp 1233125. 
Jeener, J.. Meier, B.H., Bachmann, P. and Ernst. R.R. (1979) J. 
Chem. Phys. 71, 45464553. 
Hsu. V.L., Handschumacher, R.E. and Armitage, I.M. (1990) J. 
Chem. Sot. 112, 6745-6747. 
London, R.E.. Davis, D.G.. Vavrek. R.J., Stewart, J.M. and 
Handschumacher. R.E. (1990) Biochemistry 29, 10298810302. 
Kordel, J.. Drakenberg, T.. Forsen, S. and Thuhn, E. (1990) 
FEBS Lett. 263. 27-30. 
Epstein, S.. Schlosberg, M., Fallon. M.. Thomas, S.. Movsowitz, 
C. and Ismail, F. (1990) Calcif. Tissue Int. 47. 152-157. 
Schlosberg. M.. Movsowitz, C.. Epstein. S., Ismail, F.. Fallon. M. 
and Thomas. S. (1989) Endocrinologie 124. 2179-2184. 
Choe. B.. Cook. G.W. and Krishna. N.R. (1991) J. Magn. Reson. 
94, 387-393. 
202 
